Phytopharmaceuticals

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 04.06.2021

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

A phytopharmaceutical generally consists of a complex mixture of several plant constituents. Under pharmaceutical law (according to § 10 AMG), the totality of the ingredients is the active ingredient of a phytopharmaceutical. Phytopharmaceuticals are the basis of rational phytotherapy.
It makes sense to subdivide the ingredients according to the following criteria:

  • Main active ingredient (=effectors), which are clearly responsible for the clinical efficacy alone (e.g. atropine in belladonna).
  • active substances and side-effect substances with only efficacy-determining character (e.g. chamazulene in camomile flowers)
  • Concomitant substances (= co-effectors) which are not directly involved in the effect, but which can positively or negatively influence the pharmacokinetics of the effect-determining ingredients (e.g. saponins in digitalis leaves).
  • Scaffolding substances for the structure of the plant cell, which are derived from substances of primary metabolism e.g. (cellulose)
  • Lead substances: lead substances are defined as substances that are important for phytochemical quality testing (regardless of whether they are involved in efficacy)

Literature
This section has been translated automatically.

  1. Schilcher H (2016) Guide to Phytotherapy. Urban & Fischer Munich p.9

Outgoing links (1)

Evidence-Based Phytotherapy ;